艾德生物
(300685)
| 流通市值：77.99亿 | | | 总市值：78.10亿 |
| 流通股本：3.90亿 | | | 总股本：3.90亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,068,875,627.32 | 1,065,871,209.55 | 1,037,365,789.66 | 984,160,214.99 |
| 交易性金融资产 | 363,301,257.55 | 275,963,477.56 | 277,652,676.1 | 242,347,632.37 |
| 应收票据及应收账款 | 605,092,471.63 | 652,883,971.53 | 617,107,027.55 | 617,275,719.79 |
| 其中：应收票据 | 12,953,383.99 | 7,939,145.11 | 20,551,644.74 | 20,630,271.31 |
| 应收账款 | 592,139,087.64 | 644,944,826.42 | 596,555,382.81 | 596,645,448.48 |
| 预付款项 | 13,821,013.41 | 9,944,996.66 | 11,089,948.92 | 13,345,315.03 |
| 其他应收款合计 | 1,948,138.75 | 1,775,610.65 | 2,920,149.19 | 1,980,766.64 |
| 存货 | 46,006,964.34 | 37,338,059.2 | 43,081,908.34 | 41,873,616.88 |
| 合同资产 | 1,768,752.41 | 2,371,326.47 | 1,406,573.39 | 1,981,849.06 |
| 一年内到期的非流动资产 | - | - | - | 5,592,987.16 |
| 其他流动资产 | 9,875,740.4 | 6,790,272.02 | 5,054,586.08 | 11,451,428.05 |
| 流动资产合计 | 2,110,689,965.81 | 2,052,938,923.64 | 1,995,678,659.23 | 1,920,009,529.97 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | - | 12,405,529.02 |
| 长期股权投资 | - | - | 4,506,067.17 | 10,950,220.1 |
| 其他权益工具投资 | 50,000,000 | 50,000,000 | - | - |
| 固定资产 | 164,916,865.67 | 168,767,631.28 | 164,217,016.25 | 165,304,163.63 |
| 在建工程 | 1,813,000 | 1,813,000 | - | - |
| 使用权资产 | 7,936,229.57 | 8,832,089.33 | 10,131,894.73 | 11,312,403.5 |
| 无形资产 | 40,529,423.55 | 42,467,302.34 | 41,348,254.55 | 43,478,998.79 |
| 长期待摊费用 | 4,749,913.91 | 5,413,023.04 | 6,350,602.04 | 3,052,122.69 |
| 递延所得税资产 | 12,404,839.76 | 12,569,047.7 | 14,083,741.18 | 11,148,052.24 |
| 其他非流动资产 | 3,872,083.67 | 4,834,369 | 9,859,309.5 | 16,161,736.68 |
| 非流动资产合计 | 286,222,356.13 | 294,696,462.69 | 250,496,885.42 | 273,813,226.65 |
| 资产总计 | 2,396,912,321.94 | 2,347,635,386.33 | 2,246,175,544.65 | 2,193,822,756.62 |
| 流动负债: | | | | |
| 短期借款 | 5,568,352.43 | 1,995,284.18 | 5,004,109.59 | 5,000,000 |
| 交易性金融负债 | - | 56,909.4 | - | - |
| 应付票据及应付账款 | 27,134,141.47 | 21,945,929.51 | 19,991,658.33 | 30,043,052.22 |
| 应付账款 | 27,134,141.47 | 21,945,929.51 | 19,991,658.33 | 30,043,052.22 |
| 预收款项 | - | - | 26,990 | 48,790 |
| 合同负债 | 4,291,238.46 | 3,785,357.37 | 4,044,113.47 | 2,936,803.16 |
| 应付职工薪酬 | 21,960,978.13 | 50,920,039.96 | 51,903,772.54 | 57,134,609.33 |
| 应交税费 | 32,735,954.72 | 34,685,202.01 | 36,580,099.98 | 43,930,240.04 |
| 其他应付款合计 | 39,063,571.06 | 57,075,209.08 | 58,343,487.79 | 81,242,785.44 |
| 应付股利 | - | - | - | 23,679,436.32 |
| 一年内到期的非流动负债 | 8,425,381.71 | 7,449,289.68 | 6,702,818.61 | 4,590,311.6 |
| 其他流动负债 | 217,195.02 | 204,799.27 | 128,777.9 | 98,581.63 |
| 流动负债合计 | 139,396,813 | 178,118,020.46 | 182,725,828.21 | 225,025,173.42 |
| 非流动负债: | | | | |
| 长期借款 | 181,670,000 | 94,420,000 | 82,684,643.84 | 58,832,876.71 |
| 租赁负债 | 4,824,556.59 | 4,737,592.05 | 7,141,243.48 | 8,487,149.67 |
| 递延收益 | 13,220,875.12 | 14,324,246.83 | 14,630,284.37 | 15,814,374.89 |
| 递延所得税负债 | 197,512.44 | 89,122.72 | 71,414.33 | - |
| 非流动负债合计 | 199,912,944.15 | 113,570,961.6 | 104,527,586.02 | 83,134,401.27 |
| 负债合计 | 339,309,757.15 | 291,688,982.06 | 287,253,414.23 | 308,159,574.69 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 391,536,144 | 391,536,144 | 391,536,144 | 391,536,144 |
| 资本公积 | 111,882,018.5 | 111,882,018.5 | 122,083,374.87 | 122,343,577.15 |
| 减:库存股 | 107,839,046.08 | 25,450,679.07 | 33,280,362.28 | 33,267,132.28 |
| 其他综合收益 | 1,007,892.67 | 2,268,031.17 | 2,249,654.86 | 2,199,060.22 |
| 盈余公积 | 182,301,408.71 | 182,301,408.71 | 149,842,444.59 | 149,842,444.59 |
| 未分配利润 | 1,478,714,146.99 | 1,393,409,480.96 | 1,326,490,874.38 | 1,253,009,088.25 |
| 归属于母公司股东权益合计 | 2,057,602,564.79 | 2,055,946,404.27 | 1,958,922,130.42 | 1,885,663,181.93 |
| 股东权益合计 | 2,057,602,564.79 | 2,055,946,404.27 | 1,958,922,130.42 | 1,885,663,181.93 |
| 负债和股东权益合计 | 2,396,912,321.94 | 2,347,635,386.33 | 2,246,175,544.65 | 2,193,822,756.62 |
| 公告日期 | 2026-04-28 | 2026-04-16 | 2025-10-25 | 2025-07-29 |
| 审计意见(境内) | | 标准无保留意见 | | |